Enoxaparin Increases D6 Receptor Expression and Restores Cytoskeleton Organization in Trophoblast Cells from Preeclampsia

Cells. 2022 Jun 27;11(13):2036. doi: 10.3390/cells11132036.

Abstract

D6 is a scavenger receptor for CC chemokines expressed in the human placenta. It prevents excessive leukocyte tissue infiltration by internalizing chemokines through cytoskeleton-dependent intracellular transport. In preeclampsia (PE), the D6 receptor is overexpressed in trophoblast cells, but functionally impaired, due to cytoskeleton destructuring. Low molecular weight heparin (LMWH) represents a potential treatment for PE based on its anti-thrombotic and anti-inflammatory properties. Here, we investigated the effect of enoxaparin on D6 expression, and cytoskeleton organization primary cytotrophoblast cell cultures were obtained from the placentae of women with PE (n = 9) or uncomplicated pregnancy (n = 9). We demonstrated that enoxaparin is able to (i) increase D6 expression, and (ii) improve cytoskeletal fiber alignment in trophoblast cells from PE patients.

Keywords: D6; chemokines; cytoskeleton; heparin; placenta; preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytoskeleton / metabolism
  • Enoxaparin / metabolism
  • Enoxaparin / pharmacology
  • Female
  • Heparin, Low-Molecular-Weight
  • Humans
  • Pre-Eclampsia* / metabolism
  • Pregnancy
  • Trophoblasts* / metabolism

Substances

  • Enoxaparin
  • Heparin, Low-Molecular-Weight

Grants and funding

This research was supported by the Italian Ministry of Health (Ministero della Salute-Ricerca Corrente).